BlackRock’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,201,538
| Closed | -$39.9M | – | 5146 |
|
|
2020
Q3 | $39.9M | Sell |
2,201,538
-100,698
| -4% | -$1.83M | ﹤0.01% | 2373 |
|
|
2020
Q2 | $31.5M | Buy |
2,302,236
+490,512
| +27% | +$6.72M | ﹤0.01% | 2507 |
|
|
2020
Q1 | $25.9M | Sell |
1,811,724
-49,292
| -3% | -$705K | ﹤0.01% | 2440 |
|
|
2019
Q4 | $31.5M | Sell |
1,861,016
-63,446
| -3% | -$1.07M | ﹤0.01% | 2599 |
|
|
2019
Q3 | $29.6M | Buy |
1,924,462
+17,050
| +0.9% | +$262K | ﹤0.01% | 2568 |
|
|
2019
Q2 | $44.7M | Buy |
1,907,412
+21,377
| +1% | +$501K | ﹤0.01% | 2366 |
|
|
2019
Q1 | $53.4M | Sell |
1,886,035
-125,394
| -6% | -$3.55M | ﹤0.01% | 2226 |
|
|
2018
Q4 | $60.6M | Buy |
2,011,429
+113,784
| +6% | +$3.43M | ﹤0.01% | 2111 |
|
|
2018
Q3 | $66.5M | Sell |
1,897,645
-3,902
| -0.2% | -$137K | ﹤0.01% | 2213 |
|
|
2018
Q2 | $45.1M | Buy |
1,901,547
+121,184
| +7% | +$2.87M | ﹤0.01% | 2401 |
|
|
2018
Q1 | $45.6M | Sell |
1,780,363
-45,789
| -3% | -$1.17M | ﹤0.01% | 2309 |
|
|
2017
Q4 | $31.7M | Buy |
1,826,152
+988,200
| +118% | +$17.2M | ﹤0.01% | 2516 |
|
|
2017
Q3 | $23.2M | Buy |
+837,952
| New | +$23.2M | ﹤0.01% | 2696 |
|